Yang, Fenghua
Bian, Tong https://orcid.org/0000-0003-0501-8288
Zhan, Xiechao https://orcid.org/0000-0003-3084-5656
Chen, Zhe https://orcid.org/0000-0002-5303-9879
Xing, Zhihan
Larsen, Nicolas A. https://orcid.org/0000-0001-9210-3450
Zhang, Xiaofeng https://orcid.org/0000-0002-9658-5917
Shi, Yigong https://orcid.org/0000-0003-2030-168X
Article History
Received: 12 November 2022
Accepted: 3 February 2023
First Online: 17 February 2023
Competing interests
: N.A.L. is an employee of Foghorn Therapeutics, Inc. The remaining authors declare no competing interests.